జర్నల్ ఆఫ్ ఎయిడ్స్ & క్లినికల్ రీసెర్చ్

Modelling Treatment Response Could Reduce Virological Failure in Different Patient Populations

Abstract

Andrew D Revell, Dechao Wang, Gabriella dÂ’Ettorre, Frank DE Wolf, Brian Gazzard, Giancarlo Ceccarelli, Jose Gatell, María Jésus Pérez-elías, Vincenzo Vullo, Julio S Montaner, H Clifford Lane and Brendan A Larder

Background: HIV drug resistance can cause viral re-bound in patients on combination antiretroviral therapy, requiring a change in therapy to re-establish virological control. The RDI has developed computational models that predict response to combination therapy based on the viral genotype, viral load, CD4 count and treatment history. Here we compare two sets of models developed with different levels of treatment history information and test their generalisability to new patient populations.

Methods: Two sets of five random forest models were trained to predict the probability of virological response (follow-up viral load <50 copies/ml viral RNA) following a change in antiretroviral therapy using the baseline viral load, CD4 count, genotype and treatment history from 7,263 treatment change episodes. One set used six treatment history variables and the other 18 - one for each drug. The accuracy of the models was assessed in terms of the area under the receiver-operator characteristic curve (AUC) during cross validation and with 375 TCEs from clinics that had not contributed data to the training set.

Results: The mean AUC achieved by the two sets of models during cross validation was 0·815 and 0.820. Mean overall accuracy was 75% and 76%, sensitivity 64% and 62% and specificity 81% and 84%. The AUC for each committee tested with the independent test set was 0.87 and 0.855. Mean overall accuracy was 89% and 87%, sensitivity 67% and 61% and specificity 90% and 87%. There were no significant differences between the two sets. The models correctly predicted 330 (92%) of the 357 treatment failures observed in practice and were able to identify alternative regimens that were predicted to be effective for up to 267 (75%) of the failures and regimens with a higher probability of response for all cases.

Conclusions: Computational models can predict accurately the virological response to antiretroviral therapy from a range of variables including genotype and treatment history even for patients from unfamiliar settings. This approach has potential utility as a useful aid to treatment decision-making and may reduce treatment failure